TY - JOUR T1 - Clinical meanings of rapid serological assay in patients tested for SARS-Co2 RT-PCR JF - medRxiv DO - 10.1101/2020.04.03.20052183 SP - 2020.04.03.20052183 AU - Angelo VirgilioParadiso AU - Simona De Summa AU - Daniela Loconsole AU - Vito Procacci AU - Anna Sallustio AU - Francesca Centrone AU - Nicola Silvestris AU - Vito Cafagna AU - Giuseppe De Palma AU - Antonio Tufaro AU - Vito Garrisi AU - Maria Chironna Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/04/06/2020.04.03.20052183.abstract N2 - Background RT-PCR test for identification of viral nucleic acid is the current standard diagnostic method for the diagnosis of COVID-19 disease but technical reasons limit the utilization of this assay onlarge scalescreenings.Method We verified in a consecutive series of 191 symptomatic patients the clinical information that new rapid serological colorimetric test qualitatively analyzing IgM/IgG expression can provide with respect to standard assay and with respect to clinical outcome of patients.Results Rapid serological test showed a sensitivity of 30% and a specificity of 89% with respect to the standard assay but, interestingly, these performances improve after 8 days of symptoms appearance. After 10 days of symptoms the predictive value of rapid serological test is higher than that of standardassay. When the behaviour of the two immunoglobulins was evaluated with respect to time length of symptoms appaerance, no significant difference in immunoglobulins behaviour was shown.Conclusions The rapid serological test analyzed in the present study is candidate to provide information on immunoreaction of the subject to COVID-19 exposure.Competing Interest StatementThe authors have declared no competing interest.Funding StatementPartially funded by Ministry of Health-Italian Government, Ricerca Corrente 2020Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are displayed in the manuscript. ER -